Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
Post-market: 10.620.00000.00%19:30 EDT
Volume:126.31K
Turnover:1.35M
Market Cap:372.41M
PE:-88.50
High:10.88
Open:10.78
Low:10.59
Close:10.78
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.64
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.77
PE(LYR):-31.16

Loading ...

Jun 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Major Issues Report

Form 8-K - Current report